Arcam AB, listed on NASDAQ Stockholm, has received an order for five Arcam Q10 systems from Beijing AK Medical, a present customer in China. The systems will be used for volume production of orthopedic implants.
Beijing AK Medical, established in 2003, is in the orthopedic industry specialized in researching, developing, manufacturing and sale of artificial joint prosthesis and its complete set of surgical instruments. Beijing AK Medical is a customer to Arcam since 2010 and announced in August that they received formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM manufactured implants. This was the first CFDA marketing approval for an additively manufactured orthopedic implant.
“We are happy to present this order from Beijing AK Medical, a customer since long and a leading Chinese Implant manufacturer, driving the adaptation to Additive Manufacturing in China. This order also shows that the implant industry in China is now moving to volume production of medical implants with our EBM technology”,
says Magnus René, CEO of Arcam.
“We are excited to move into volume production with the EBM technology. Having worked with Arcam since 2010 we are now ramping up our activities, following the recent approval by the CFDA”, says Mr Li Zhi Jiang, CEO of Beijing AK Medical.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail: magnus [dot] rene [at] arcam [dot] com